UBS Group
MDT icon

UBS Group’s Medtronic MDT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$498M Buy
5,713,158
+662,193
+13% +$57.7M 0.09% 189
2025
Q1
$454M Buy
5,050,965
+139,334
+3% +$12.5M 0.08% 197
2024
Q4
$392M Buy
4,911,631
+734,267
+18% +$58.7M 0.07% 210
2024
Q3
$376M Sell
4,177,364
-114,678
-3% -$10.3M 0.08% 188
2024
Q2
$338M Buy
4,292,042
+196,723
+5% +$15.5M 0.08% 183
2024
Q1
$357M Buy
4,095,319
+340,060
+9% +$29.6M 0.09% 175
2023
Q4
$309M Sell
3,755,259
-261,945
-7% -$21.6M 0.09% 169
2023
Q3
$315M Sell
4,017,204
-465,003
-10% -$36.4M 0.11% 149
2023
Q2
$395M Sell
4,482,207
-2,247,951
-33% -$198M 0.13% 127
2023
Q1
$543M Sell
6,730,158
-313,008
-4% -$25.2M 0.2% 91
2022
Q4
$547M Sell
7,043,166
-985,567
-12% -$76.6M 0.2% 87
2022
Q3
$648M Sell
8,028,733
-1,046,445
-12% -$84.5M 0.28% 60
2022
Q2
$814M Sell
9,075,178
-174,779
-2% -$15.7M 0.33% 53
2022
Q1
$1.03B Sell
9,249,957
-935,077
-9% -$104M 0.34% 47
2021
Q4
$1.05B Sell
10,185,034
-287,195
-3% -$29.7M 0.3% 45
2021
Q3
$1.31B Sell
10,472,229
-521,364
-5% -$65.4M 0.41% 28
2021
Q2
$1.36B Sell
10,993,593
-208,770
-2% -$25.9M 0.44% 28
2021
Q1
$1.32B Sell
11,202,363
-1,176,359
-10% -$139M 0.44% 25
2020
Q4
$1.45B Buy
12,378,722
+235,981
+2% +$27.6M 0.49% 18
2020
Q3
$1.26B Sell
12,142,741
-544,601
-4% -$56.6M 0.48% 26
2020
Q2
$1.16B Sell
12,687,342
-954,661
-7% -$87.5M 0.49% 26
2020
Q1
$1.23B Sell
13,642,003
-1,299,517
-9% -$117M 0.58% 21
2019
Q4
$1.7B Sell
14,941,520
-632,521
-4% -$71.8M 0.59% 20
2019
Q3
$1.69B Sell
15,574,041
-1,110,758
-7% -$121M 0.65% 18
2019
Q2
$1.62B Buy
16,684,799
+1,677,045
+11% +$163M 0.63% 20
2019
Q1
$1.37B Buy
15,007,754
+34,173
+0.2% +$3.11M 0.56% 23
2018
Q4
$1.36B Sell
14,973,581
-176,250
-1% -$16M 0.62% 17
2018
Q3
$1.49B Buy
15,149,831
+330,542
+2% +$32.5M 0.59% 17
2018
Q2
$1.27B Sell
14,819,289
-44,851
-0.3% -$3.84M 0.55% 21
2018
Q1
$1.19B Buy
14,864,140
+1,076,594
+8% +$86.4M 0.51% 21
2017
Q4
$1.11B Buy
13,787,546
+1,050,215
+8% +$84.8M 0.46% 22
2017
Q3
$991M Buy
12,737,331
+992,008
+8% +$77.1M 0.46% 22
2017
Q2
$1.04B Buy
11,745,323
+851,050
+8% +$75.5M 0.54% 18
2017
Q1
$878M Buy
10,894,273
+1,032,236
+10% +$83.2M 0.48% 25
2016
Q4
$702M Sell
9,862,037
-216,166
-2% -$15.4M 0.39% 31
2016
Q3
$871M Buy
10,078,203
+62,059
+0.6% +$5.36M 0.52% 16
2016
Q2
$869M Buy
10,016,144
+603,567
+6% +$52.4M 0.55% 13
2016
Q1
$706M Buy
9,412,577
+434,344
+5% +$32.6M 0.47% 21
2015
Q4
$691M Buy
8,978,233
+405,194
+5% +$31.2M 0.45% 22
2015
Q3
$574M Buy
8,573,039
+225,537
+3% +$15.1M 0.41% 25
2015
Q2
$619M Buy
8,347,502
+155,287
+2% +$11.5M 0.41% 25
2015
Q1
$639M Sell
8,192,215
-265,059
-3% -$20.7M 0.44% 26
2014
Q4
$611M Buy
+8,457,274
New +$611M 0.43% 26